The updated formula for Moderna’s COVID-19 vaccine generates a 16-fold increase in antibodies neutralize the intended SARS-CoV-2 variant.

Scientists have conducted breakthrough research that could lead to a universal cancer vaccine, revolutionizing how the disease is treated.

This is the time of year when updated boosters for COVID-19 are typically available. But this year has been anything but typical.

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups Clinical findings reinforce preclinical data ...

San Francisco will follow vaccine recommendations from a coalition of western states as upheaval continues with federal ...

A Florida pharmacy licensing board on Tuesday made clear that prescriptions aren’t necessary for patients who want to get ...

Moderna said today its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older ...

The protein-based vaccine now covers the LP.8.1 variant and can be given to adolescents aged 12 years or older who previously ...

People are still debating whether the mRNA from COVID-19 vaccines remains in the body longer than it should. Some say it ...

Moderna's 2025-2026 mNEXSPIKE showed strong immune response and safety in Phase 4 trials, reinforcing FDA approval for the LP.8.1-targeting formula.

Dr. Kawsar Talaat, Associate Professor of Global Disease Epidemiology and Control at John’s Hopkins University, joins Casey Phillips, guest host of Bloom, guest host for Bloom, to explain ...

President Donald Trump used his platform to promote unproven and in some cases discredited ties between Tylenol, vaccines and ...